Registration

AVANIR PHARMACEUTICALS for AVANIR PHARMACEUTICALS

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE New Director of Advocacy
CRYSTAL LYNN VANUCH New Head of Government Affairs

Pharmacy PHA

Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE New Director of Advocacy
CRYSTAL LYNN VANUCH New Head of Government Affairs

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.